Tuberculosis(TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies. The first line of treatment is mostly preferred and widely available across the world. However, with growing resistant to antibiotics, there is an increasing demand of innovative drug resistant TB medications to be widely available. These factors, along with others, drive the anti- tuberculosis therapeutics market.

1. INTRODUCTION 

2. RESEARCH METHODOLOGY 

3. EXECUTIVE SUMMARY 

4. MARKET DYNAMICS 

5. MARKET SEGMENTATION 

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE 

7. FUTURE OF THE MARKET